Aktis Oncology vs Thermo Fisher Scientific

Side-by-side comparison of AI visibility scores, market position, and capabilities

Thermo Fisher Scientific leads in AI visibility (79 vs 53)
Aktis Oncology logo

Aktis Oncology

ChallengerHealthcare & Life Sciences

Radiopharmaceuticals

Clinical-stage oncology company completed $318M IPO in Jan 2026 — first biotech IPO of 2026 (Nasdaq: AKTS); Eli Lilly took $100M stake; developing alpha-emitting radiopharmaceutical AKY-1189 targeting Nectin-4 for bladder and other solid tumors.

AI VisibilityBeta
Overall Score
C53
Category Rank
#252 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
52
Perplexity
57
Gemini
53

About

Aktis Oncology is a Boston-based clinical-stage oncology company developing alpha-emitting radiopharmaceuticals against prevalent solid tumors. The company completed a $318 million IPO in January 2026 — the first significant biotech IPO of 2026 — pricing 17.65 million shares at $18 each on the Nasdaq under ticker AKTS. Eli Lilly stepped in to purchase $100 million of the offering.

Full profile
Thermo Fisher Scientific logo

Thermo Fisher Scientific

LeaderHealthcare Tech

Enterprise

Thermo Fisher (TMO) reported $42.9B revenue in FY2024, down 1% YoY. World's #1 life sciences company. Serves pharma, biotech, labs globally. ~100,000 employees. HQ: Waltham, MA.

AI VisibilityBeta
Overall Score
B79
Category Rank
#24 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
81
Perplexity
79
Gemini
85

About

Thermo Fisher Scientific Inc. is the world's largest life sciences company, providing analytical instruments, reagents, consumables, software, and services to researchers, healthcare organizations, and industrial companies. Headquartered in Waltham, Massachusetts, Thermo Fisher was formed through the 2006 merger of Thermo Electron and Fisher Scientific and has since grown aggressively through acquisitions. The company reported revenues of $42.9B in FY2024, slightly down year-over-year after exceptional COVID-related revenue in 2021–2022.

Full profile

AI Visibility Head-to-Head

53
Overall Score
79
#252
Category Rank
#24
78
AI Consensus
80
stable
Trend
stable
52
ChatGPT
81
57
Perplexity
79
53
Gemini
85
47
Claude
77
54
Grok
77

Key Details

Category
Radiopharmaceuticals
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Aktis Oncology
Radiopharmaceuticals

Integrations

Both integrate with
Only Thermo Fisher Scientific
Thermo Fisher Scientific is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.